3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
9
Terminated
4
Active not recruiting
3
Withdrawn
1
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Tuberous Sclerosis
2
Vascular Malformations
1
Triple Negative Breast Neoplasms
1
Peutz-Jeghers Syndrome
1
Perivascular Epithelioid Cell Neoplasms
1
Pancreatic Neoplasms
1
Neoplasms
1
Malignant Solid Tumors
1
Lymphangioma
1
Lymphangioleiomyomatosis
1
Leiomyoma
1
Kaposiform Hemangioendothelioma
1
Hereditary Sensory and Autonomic Neuropathies
1
Hematologic Neoplasms
1
Hemangioendothelioma
1
Graft vs Host Disease
1
Epilepsy
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Advanced Solid Tumors
1
Interventions
Exercise
19
Drug Therapy
18
pembrolizumab
13
Capecitabine
11
Blood Specimen Collection
11
Surveys and Questionnaires
10
Radiotherapy
10
Paclitaxel
9
Dexamethasone
9
Nivolumab
8
Standard of Care
7
Oxaliplatin
7
Fluorouracil
7
Erlotinib Hydrochloride
7
apatinib
6
Interviews as Topic
6
Gemcitabine
6
Control Groups
6
Cisplatin
6
Therapeutics
5
Neoadjuvant Therapy
5
Mindfulness-Based Cognitive Therapy
5
Metformin
5
Injections
5
Everolimus
5
Docetaxel
5
Cyclophosphamide
5
Bevacizumab
5
sintilimab
4
atezolizumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Neoplasms
×
Sirolimus
×
Clear all
NCT04987463
2024-02-08
ViRap
Children's Memorial Health Institute, Poland
Phase 2/3
Unknown
60 enrolled